Physician profile
Robert Tung
NPI 1306308788
$4,598.11
in general payments reported to CMS, 2019-2025
9 companies · $2,188 in 2025
The $2,188 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.12 · 2023: $745 · 2024: $1,615 · 2025: $2,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,113 · Travel and Lodging: $1,180 · Education: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,113.38 |
| Travel and Lodging | $1,179.62 |
| Education | $254.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,777.01 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Axogen | $766.33 | 2025 | |
| Stryker Corporation | $254.99 | 2024 | |
| Medtronic, INC. | $155.69 | 2024 | V-Loc 180 |
| Depuy Synthes Sales INC. | $142.86 | 2025 | Trumatch, Matrixmandible, Matrixmidface |
| Polynovo North America LLC | $131.82 | 2024-2025 | Novosorb Btm |
| Baxter Healthcare | $119.27 | 2025 | Artiss |
| Integra Lifesciences Corporation | $111.24 | 2024 | Tenoglide |
| Smith+Nephew, INC. | $88.78 | 2024 | Oasis, Stravix, Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.